tradingkey.logo

Rxsight Inc

RXST
View Detailed Chart

7.850USD

+0.050+0.64%
Market hours ETQuotes delayed by 15 min
318.62MMarket Cap
LossP/E TTM

Rxsight Inc

7.850

+0.050+0.64%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.64%

5 Days

-1.51%

1 Month

-39.85%

6 Months

-76.71%

Year to Date

-77.17%

1 Year

-81.21%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 11 analysts
HOLD
Current Rating
11.625
Target Price
49.04%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
8
Average
Company name
Ratings
Analysts
Rxsight Inc
RXST
11
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(3)
Buy(2)
Indicators
Sell(3)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.467
Neutral
RSI(14)
29.963
Sell
STOCH(KDJ)(9,3,3)
56.418
Neutral
ATR(14)
0.405
Low Volatility
CCI(14)
26.494
Neutral
Williams %R
44.425
Buy
TRIX(12,20)
-2.111
Sell
StochRSI(14)
54.850
Sell
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
7.852
Sell
MA10
7.768
Buy
MA20
8.226
Sell
MA50
12.007
Sell
MA100
15.178
Sell
MA200
26.834
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.
Ticker SymbolRXST
CompanyRxsight Inc
CEODr. Ron M. Kurtz, M.D.
Websitehttps://www.rxsight.com/
KeyAI